FLT3 and acute myeloid leukemia: FLT3 mutations occur either as internal tandem duplications (FLT3/ITD, 24% of AML) or as point mutations resulting in single amino acid substitutions within the activation loop of the tyrosine kinase domain (FLT3/TKD, 7% of AML), resulting in a constitutively active kinase [15,16].